Metaclipse Therapeutics' Incubator/Accelerator Round

Metaclipse Therapeutics raised a round of funding on March 02, 2016. Investors include JLabs.

Metaclipse Therapeutics is developing a personalized cancer immunotherapy using tumor membrane vesicles prepared from the patient's own tumor and combined with immune-stimulatory molecules.…

Articles about Metaclipse Therapeutics' Incubator/Accelerator Round: